AbbVie (ABBV) Accumulated Depreciation & Amortization (2012 - 2025)

AbbVie (ABBV) has 14 years of Accumulated Depreciation & Amortization data on file, last reported at $7.9 billion in Q4 2025.

• Accumulated Depreciation & Amortization for Q4 2025 came in at $7.9 billion, up 10.78% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.9 billion (up 10.78% YoY), and the FY2025 annual result was $7.9 billion, up 10.78% from the prior year.
• Accumulated Depreciation & Amortization improved to $7.9 billion in Q4 2025 per ABBV's latest filing, from $7.1 billion in the prior quarter.
• Over five years, Accumulated Depreciation & Amortization peaked at $7.9 billion in Q4 2025 and troughed at $5.6 billion in Q4 2021.
• A 5-year average of $6.7 billion and a median of $6.6 billion in 2023 frame the typical range for Accumulated Depreciation & Amortization.
• The sharpest annual moves came in 2021 and 2025: Accumulated Depreciation & Amortization increased 0.11% in 2021, then grew 10.78% in 2025.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $5.6 billion in 2021, then increased by 7.73% to $6.1 billion in 2022, then grew by 9.83% to $6.6 billion in 2023, then grew by 7.33% to $7.1 billion in 2024, then climbed by 10.78% to $7.9 billion in 2025.
• Business Quant data shows ABBV's Accumulated Depreciation & Amortization at $7.9 billion in Q4 2025, $7.1 billion in Q4 2024, and $6.6 billion in Q4 2023.